Factors Determining δ-Bilirubin Levels in Infants With Biliary Atresia
- PMID: 25564820
- PMCID: PMC4409472
- DOI: 10.1097/MPG.0000000000000690
Factors Determining δ-Bilirubin Levels in Infants With Biliary Atresia
Abstract
Objectives: δ-Bilirubin (Bδ) forms when bilirubin conjugates covalently bind to albumin by way of nonenzymatic transesterification in patients with cholestasis. Infants with cholestasis with biliary atresia form Bδ. The aim of the present study was to investigate the factors determining serum Bδ concentrations in infants with biliary atresia.
Methods: Study patients were infants enrolled in a prospective study (PROBE: Clinicaltrials.gov NCT00061828) of biliary atresia. We acquired data of concurrently measured serum bilirubin analytes (total bilirubin [TB], conjugated bilirubin [Bc], and unconjugated bilirubin) and applied graphical methods and linear mixed effects model to study factors contributing to Bδ variability.
Results: Bδ level increased with increasing levels of Bc and TB. In addition, the length of time cholestasis persisted partially determined the level of Bδ. An increase of 1 mg/dL in Bc is related to approximately 0.36 mg/dL increase in Bδ (P < 0.0001); every 100 days of cholestasis is associated with an approximately 1.0 mg/dL increase in Bδ (P < 0.0001) given the same level of Bc. Serum albumin levels are not significantly related to Bδ (P = 0.89).
Conclusions: Bδ levels in infants with biliary atresia increase with increasing levels of Bc and longer duration of cholestasis. Understanding the relation among Bδ, Bc, TB, and direct-reacting bilirubin levels can help in interpretation of the clinical extent of cholestasis in infants and children with biliary atresia, assisting in the diagnosis and management of these infants.
Conflict of interest statement
Conflicts of Interest and Source of Funding: None
Figures
References
-
- Flaherman VJ, Kuzniewicz MW, Escobar GJ, et al. Total serum bilirubin exceeding exchange transfusion thresholds in the setting of universal screening. J Pediatr. 2012;160:796–800. e1. - PubMed
-
- Gartner LM, Herrarias CT, Sebring RH. Practice patterns in neonatal hyperbilirubinemia. Pediatrics. 1998;101:25–31. - PubMed
-
- Arvan D, Shirey TL. Conjugated bilirubin: a better indicator of impaired hepatobiliary excretion than direct bilirubin. Ann Clin Lab Sci. 1985;15:252–259. - PubMed
-
- Moyer V, Freese DK, Whitington PF, et al. Guideline for the evaluation of cholestatic jaundice in infants: recommendations of the North American Society for Pediatric Gastroenterology, Hepatology and Nutrition. J Pediatr Gastroenterol Nutr. 2004;39:115–128. - PubMed
-
- Rosenthal P, Keefe MT, Henton D, et al. Ektachem and unconjugated bilirubin measurements. J Clin Chem Clin Biochem. 1989;27:829. - PubMed
Publication types
MeSH terms
Substances
Associated data
Grants and funding
- U01 DK062481/DK/NIDDK NIH HHS/United States
- DK 62452/DK/NIDDK NIH HHS/United States
- U01 DK103135/DK/NIDDK NIH HHS/United States
- M01 RR000048/RR/NCRR NIH HHS/United States
- U01 DK062452/DK/NIDDK NIH HHS/United States
- U01 DK062466/DK/NIDDK NIH HHS/United States
- DK 84536/DK/NIDDK NIH HHS/United States
- DK 84575/DK/NIDDK NIH HHS/United States
- U01 DK084575/DK/NIDDK NIH HHS/United States
- U01 DK084536/DK/NIDDK NIH HHS/United States
- P30 DK020572/DK/NIDDK NIH HHS/United States
- DK 62481/DK/NIDDK NIH HHS/United States
- U24 DK062456/DK/NIDDK NIH HHS/United States
- DK 62466/DK/NIDDK NIH HHS/United States
- DK 62470/DK/NIDDK NIH HHS/United States
- DK 62503/DK/NIDDK NIH HHS/United States
- U01 DK062470/DK/NIDDK NIH HHS/United States
- DK 62445/DK/NIDDK NIH HHS/United States
- DK 62497/DK/NIDDK NIH HHS/United States
- DK 62456/DK/NIDDK NIH HHS/United States
- U01 DK084538/DK/NIDDK NIH HHS/United States
- U01 DK062453/DK/NIDDK NIH HHS/United States
- P30 DK026743/DK/NIDDK NIH HHS/United States
- U01 DK062503/DK/NIDDK NIH HHS/United States
- DK 62436/DK/NIDDK NIH HHS/United States
- DK 62453/DK/NIDDK NIH HHS/United States
- U01 DK062436/DK/NIDDK NIH HHS/United States
- DK 62500/DK/NIDDK NIH HHS/United States
- UL1 TR001082/TR/NCATS NIH HHS/United States
- U01 DK062456/DK/NIDDK NIH HHS/United States
- U01 DK062445/DK/NIDDK NIH HHS/United States
- DK 84538/DK/NIDDK NIH HHS/United States
- U01 DK062500/DK/NIDDK NIH HHS/United States
- U01 DK062497/DK/NIDDK NIH HHS/United States
